GelStat Corporation (GSAC) Stock Analysis & Winston Score

GelStat Corporation is a small specialty pharmaceutical company that develops and sells over-the-counter health products. Its main product is GelStat Migraine, a homeopathic remedy designed to help people manage migraine headaches without a prescription. The company sells directly to consumers, making it part of the self-care and OTC drug market rather than the prescription drug world.

GelStat earns revenue through product sales, and its 75% gross margin suggests the cost to make its products is relatively low. However, the company's deeply negative operating margin means it is spending far more than it earns, which is a serious concern for its long-term survival. The company is very small, with essentially no measurable market capitalization, and it faces stiff competition from well-established OTC pain and migraine brands with much larger marketing budgets. The central risk is whether the company can grow sales fast enough to cover its operating costs before it runs out of resources.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+2.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

YoY Growth Rate

EPS data limited

Insider Activity

14.2%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~2 months

$9,627 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

GelStat Corporation has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

86.4%

Premium pricing power — 86.4% gross margin

Operating Margin

-87.0%

Losing money on operations — -87.0%

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+62.9%

Fast-growing sales (62.9% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-10.5%

Burning cash (-10.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial